Cyclic Guanosine Monophosphate and 10-Year Change in Left Ventricular Mass: the Multi-Ethnic Study of Atherosclerosis (MESA)

Cyclic guanosine monophosphate (cGMP) is a second messenger for natriuretic peptide (NP) and nitric oxide pathways; its enhancement a target for heart failure and cardiovascular disease (CVD). We evaluated whether plasma cGMP was associated with change in left ventricular mass (LVM) among individual...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biomarkers
Main Authors: Subramanya, Vinita, Zhao, Di, Ouyang, Pamela, Ying, Wendy, Vaidya, Dhananjay, Ndumele, Chiadi E., Lima, Joao A., Guallar, Eliseo, Hoogeveen, Ron C., Shah, Sanjiv J., Heckbert, Susan R., Kass, David A., Post, Wendy S., Michos, Erin D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8281442/
https://ncbi.nlm.nih.gov/pubmed/33715578
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/1354750X.2021.1893811
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados